Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Symptom C0153690|bone metastasis
Sentences 29
PubMedID- 26335399 In lung cancer patients with bone metastasis, the circulating metastatic cells were found to have increased inos expression contributing to increase in epithelial cell adhesion molecule (epcam) which is associated with metastasis due to reduced cell-cell-adhesion .
PubMedID- 25059970 Risk factors for bone metastasis in patients with primary lung cancer: study protocol for a systematic review.
PubMedID- 20015657 The objective of our study was to compare the sensibility of the 2-deoxy-2-18f fluoro-d-glucose positron emission tomography/computed tomography (f-18 fdg pet/ct) for the detection of bone metastasis in patients with non-small-cell lung cancer (nsclc) whose technetium 99m methylenediphosphonate (tc-99m mdp) bone scans were absolutely normal.
PubMedID- 25738754 Therefore, tcn may be a novel agent for treatment of nonsmall cell lung cancer patients with bone metastasis.
PubMedID- 26521996 Objective: in this study, an evaluation was made of the relationship between the serum levels of carcinoembryonic antigen (cea), osteopontin (opn), and the semi-quantitative parameters of 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18f-fdg pet/ct) in lung cancer patients with bone metastasis.
PubMedID- 26044862 bone metastasis in lung cancer results in an unfavorable outcome for patients by not only impairing the quality of life, yet also increasing the cancer-related death rates.
PubMedID- 22158485 Methods and study design: eighteen patients having non-small cell lung cancer (nsclc) with bone metastasis who received carboplatin/nedaplatin plus paclitaxel combined with zol (4 mg every 28 days) were enrolled to investigate the feasibility of this treatment.
PubMedID- 22862159 An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy.
PubMedID- 24361889 lung cancer-derived dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation.
PubMedID- 26143039 Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
PubMedID- 21094027 Conclusion: (18)fdg pet was found to be the best modality to detect bone metastasis in patients with lung cancer, both on a per-patient basis and a per-lesion basis; mri had the highest specificity on a per-lesion basis.
PubMedID- 23690878 The datasets were collected for 46 lung cancer patients with bone metastasis who had received tc-99m mdp whole-body bone scans by spect at buddhist tzu chi hospital, taipei branch.
PubMedID- 20608863 A 60-year-old male patient suffering from a non-small cell lung cancer with bone metastasis was under treatment with docetaxel and developed acral erythema involving photoexposed areas.
PubMedID- 24581154 Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version).
PubMedID- 22729551 Comparison of diagnostic ability between (99m)tc-mdp bone scan and (18)f-fdg pet/ct for bone metastasis in patients with small cell lung cancer.
PubMedID- 23456204 A 66-year-old man was admitted to our hospital on suspicion of lung cancer with bone metastasis.
PubMedID- 24849432 Objective: to establish a model bearing human lung cancer xenograft with bone metastasis in mice with normal immune function.
PubMedID- 22537906 bone metastasis of lung cancer is a dynamic process involving bone resorption resulted from tumor cell-induced osteolysis and bone formation due to osteoblasts.
PubMedID- 26316819 Metastatic illness at other sites was common among lung cancer patients with bone metastasis and at least one sre.
PubMedID- 22679429 Among clinical studies, a phase iii study indicated that zoledronic acid decreased sres due to bone metastasis of non-small cell lung cancer (nsclc) 2.
PubMedID- 22672969 Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis.
PubMedID- 25263362 Objective: to investigate the effect of parathyroid hormone (1-34) (pth) on tumor growth in a mouse model of lung cancer with bone metastasis.
PubMedID- 25338281 Comparison of 99mtc-3prgd2 integrin receptor imaging with 99mtc-mdp bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study.
PubMedID- 25240518 The majority of lung cancer patients with bone metastasis will also experience an sre, which may further increase the rate of mortality.
PubMedID- 23593434 Mirna-mediated regulatory network in the bone metastasis of lung cancer.
PubMedID- 25742995 The patient also had lung cancer with vertebral bone metastasis.
PubMedID- 23276824 Prospective study of urinary and serum cross-linked n-telopeptide of type i collagen (ntx) for diagnosis of bone metastasis in patients with lung cancer.
PubMedID- 19285820 bone metastasis in patients with non-small cell lung cancer: the diagnostic role of f-18 fdg pet/ct.
PubMedID- 24419421 A, time to bone metastasis from diagnosis of lung cancer.

Page: 1